Amphetamines
Opioid substitution treatment practice guidelines February 2003
These Opioid Substitution Treatment New Zealand Practice Guidelines provide a framework for the effective, safe and responsive delivery of opioid substitution treatment and will supersede the National Protocol for Methadone Treatment in New Zealand (1996) from 1 February 2003.
National drug policy
The National Drug Policy (NDP) aims to improve the health and wellbeing of New Zealanders by encouraging the development of strategies and programmes which prevent and reduce drug-related harm.The NDP is in line with World Health Organization and United Nations recommendations of a balanced approach to drug policy.Progress under the NDP is reviewed twice yearly by the Ministerial Committee on Drug Policy (MCDP). Initiatives are progressed and monitored by a group of Government agencies that make up the Inter-Agency Committee on Drugs (IACD).
New Zealand Customs Service Annual Report 2005/06
The Customs 2005/2006 annual report, released on October 16, the report highlights remarkable achievements notably Customs New Zealand made the largest drug seizure in New Zealand's history and the signing of a Declaration of Principles with the United States are among key achievements made by the New Zealand Customs Service over the past year.
Health Select Committee report on Misuse of Drugs Act May 2005
Misuse of Drugs Amendment Bill (No 3) (186-2) and Supplementary Order Paper 298 (23 May 2005)The bill as introduced amends two main areas of the Misuse of Drugs Act 1975 (the principal Act) and the Misuse of Drugs Amendment Act 1978 (the amendment Act). The bill allows presumption of supply matters to be amended by Order in Council, subject to an affirmative resolution procedure. It also amends the presumption of supply quantity for methamphetamine, and adds a Ministry of Justice official to the membership of the Expert Advisory Committee on Drugs.
Health Select Committee report on drug classification changes April 2003
Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (9 April 2003)The Health Committee has examined the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 and recommends that the related notice of motion be approved.
Inter-Agency Committee on Drugs (IACD)
A monitoring group of officials, the IACD ensures that policies and programmes developed by government agencies are consistent and mutually supportive. The IACD also makes recommendations to the MCDP on new policy initiatives.
Ministerial Committee on Drug Policy (MCDP)
Meeting at least twice a year, the MCDP is charged with reviewing progress in implementing the National Drug Policy, and deciding which new policy initiatives should be implemented.The National Drug Policy states that the MCDP is chaired by the Minister of Health and includes the Ministers of Corrections, Customs, Justice, Police, Maori Affairs, Youth Affairs, Transport and Education.
Expert Advisory Committee on Drugs (EACD)
The Misuse of Drugs Amendment Act 2000 (the Act) established the Expert Advisory Committee on Drugs (EACD) to provide expert advice to the Minister of Health regarding drug classification issues.
